For nearly seven years, RxRights has been fighting to promote and protect access to safe and affordable medicine. Regrettably, we’re going to be forced to close our doors at the end of the month.
It pains us to announce this closure—especially as the drug pricing issue is gaining traction in the media and with legislators. We’ve ...Read more -->
We’ve been working with some allies concerned with the high cost of insulin. Through these connections, we found out about a class action lawsuit focused on insulin prices.
The lawsuit, brought by a firm called Hagens Berman, alleges that the top three insulin manufacturers, Sanofi, Novo Nordisk and Eli Lilly, have been committing fraud by illegally raising ...Read more -->
Our lead organizer, Lee Graczyk, was part of a panel in Minneapolis last week organized by Senators Amy Klobuchar (D-MN) and Tammy Baldwin (D-WI) regarding drug prices.
The panel discussed methods of lowering prescription drug prices related to the senators’ new legislation. In January, they introduced S.41, the Medicare Prescription Drug Price Negotiation Act—which would allow Medicare to ...Read more -->
The process of dismantling the Affordable Care Act began in earnest earlier this week, as the Senate held a “vote-a-rama,” before passing the budget resolution ultimately designed to repeal the bill.
During vote-a-rama, debate is limited but Senators are able to offer an unlimited number of amendments. Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) took ...Read more -->
For more than six years, RxRights has been working to promote and protect your access to safe and affordable medicine. After Martin Skhreli raised a drug’s price 5000 percent overnight late in 2015, this year began with hope of serious action to reduce drug prices.
While drug prices continued to overburden Americans in 2016, we’ve made ...Read more -->
After several years of negotiations, Congress has reached an agreement on the 21st Century Cures Act, a massive bill with a host of implications for healthcare spending.
The bill sailed through the House on November 30 with a 392 to 26 vote. A majority of the Senate voted to end debate on the bill Monday night. ...Read more -->
President-elect Donald Trump is being urged to act immediately upon assuming office to explicitly legalize the personal importation of medicine from licensed registered pharmacies in (Tier One) countries whose standards of safety and efficacy meet or exceed those of the U.S.
In an open letter to the President-elect from Lee Graczyk, lead organizer of RxRights, and ...Read more -->
We recently surveyed our supporters regarding the high price of insulin and how it affects you and your friends/family members. Since it’s National Diabetes Awareness Month, it’s an appropriate time to report our findings.
A total of 873 people responded; 653 said they don’t use insulin but care about the impact the high price of insulin ...Read more -->
You might recall that RxRights initiated a campaign last year regarding the skyrocketing price of insulin, based on your feedback. We enlisted your help to pressure drug makers and we’ve long been appealing to legislators. We’re pleased to see these efforts have been fruitful. The insulin issue is finally gaining traction with legislators and the ...Read more -->
Do you find our updates about prescription drug pricing valuable? Do you save money because you import your medications from another country?
If you answered “yes” to either of these questions, please think about how much you value our efforts to protect your access to affordable medicine. If you can, consider giving to the cause.
We recognize ...Read more -->
Price spikes for medications such as Daraprim and the EpiPen have received a lot of media attention lately. But these aren’t isolated incidents. The Wall Street Journal found the majority of the top 20 pharmaceutical companies used price hikes as a tactic to propel profits in 2016.
This profit comes at the expense of patients. Millions ...Read more -->
When criticized for high drug prices, a pharmaceutical firm will commonly cite its generous co-pay and coupon assistance programs as a solution. But a new piece by experts published in the Annals of Internal Medicine suggests these discount programs are actually part of the drug pricing problem.
The article lays out five points to back up ...Read more -->
A group of patient advocates and businesses representing the right of Americans to engage in the importation of prescription medications from safe, credentialed international pharmacies, today announced joint support of an unprecedented initiative to ensure presidential candidates Hillary Clinton and Donald Trump address the issue of prescription importation at the second presidential debate.
The group includes ...Read more -->
The House Oversight and Government Reform Committee held a hearing this week in an effort to get some answers from Heather Bresch, CEO of Mylan, regarding the company’s 500 percent EpiPen price hike.
Bresch testified along with Dr. Doug Throckmorton, deputy director of the FDA’s Center for Drug Evaluation and Research. The EpiPen auto-injector is a ...Read more -->
Representative Keith Ellison (D-MN) held a press conference on August 31 at the Minneapolis Urban League regarding the dire need for access to affordable medicine.
Holding up EpiPens an attendee brought in, Rep. Ellison spoke of the recent dramatic price hike of the life-saving allergy drug made by Mylan. “I find this price-gouging by pharmaceutical companies ...Read more -->
The Hill – Healthcare Blog
By Lee Graczyk and Tod Cooperman
The recent national political conventions would lead one to believe that there is no common ground between Hillary Clinton and Donald Trump. But that’s not the case. Beneath all of the bitter acrimony is an issue on which both of the presidential candidates agree: the legal ...Read more -->
A recent news report from Minnesota sheds a light on a widespread and underhanded tactic that has been boosting drug company profits at the expense of taxpayers for years.
Drug companies aren’t supposed to charge government programs like Medicaid and Medicare more than private health care consumers. Patients in these programs are supposed to qualify for ...Read more -->
The National Association of Boards of Pharmacy (NABP) came out with another progress report on their Internet Drug Outlet Identification Program last week that uses some of the same old scare tactics.
The report is used as justification for NABP’s .Pharmacy Top-Level Domain (TLD) Program. The program switches eligible pharmacy websites from “.com” to “.pharmacy” domains. ...Read more -->
The search engine, Bing, announced in May that it will now accept .pharmacy top-level domains as proof of online pharmacy accreditation from the National Association of Boards of Pharmacy (NABP). Bing’s ad program already requires that pharmaceutical advertisers are accredited by the NABP. If you use Bing, you may have noticed its attempts to scare ...Read more -->
A recent AARP survey found that 81% of Americans ages 50 and up think prescription drug prices are too high; nearly 9 in 10 believe our leaders need to take action to address the problem.
The two presumptive presidential candidates of the Democratic and Republican parties have voiced their support for the personal importation of prescription ...Read more -->
The Fourth of July holiday is fast approaching. I want to wish you and yours a safe and happy holiday weekend!
As residents of the United States, we have many freedoms to celebrate. But it’s also clear this country has some serious work to do in terms of ensuring access to affordable medicine, particularly for our ...Read more -->
Earlier this year, we asked you to send a message to the secretary of Health and Human Services (HHS) and the director of the National Institutes of Health (NIH) regarding the unjust pricing of the $129,000 prostate cancer drug, Xtandi. RxRights also signed on to a letter to the NIH, along with 10 other public ...Read more -->
Lee Graczyk, our lead organizer, was asked to share his expertise on the John Gambling Show on Tuesday. You can listen to the radio interview here. John’s discussion with Lee starts about 17 minutes and 30 seconds into the program.
Topics discussed include:
The fact that Medicare is prohibited from negotiating with drug companies and the history ...Read more -->
On October 15 of last year, the Department of Health and Human Services (HHS) and the FDA issued a rule giving the government the authority to seize and destroy personally imported drugs. We’ve been anxiously anticipating the fallout from this unjust regulation. And we just heard about an individual in Chicago whose medication was confiscated.
It’s ...Read more -->
Desperate people sometimes do desperate things. An 86-year-old man in Florida killed his wife of 50 years earlier this month. The reason he gave? She was suffering and they couldn’t afford her medicine.
This tragedy was preventable. We’ve seen that drug prices for brand name, generic and specialty drugs continue to rise at alarming rates. Many ...Read more -->
Last week, executives from Valeant Pharmaceuticals testified before the Senate’s Special Committee on Aging during the third in a series of hearings investigating sudden price spikes in drugs that have been around for decades.
During the three-hour hearing, Senate committee members took turns admonishing the execs for an unethical business model that put profits before patients. ...Read more -->
Electronic prescriptions became mandatory in the state of New York at the end of last month. The shift away from handwritten, paper prescriptions was sparked by prescription opioid abuse. It also aims to reduce prescription errors and integrate prescription information into electronic medical records.
As of April 2014, nine in ten community pharmacies in all 50 ...Read more -->
A recent press release by PharmacyChecker.com reminded us we haven’t posted for a while about how to go about finding a safe international online pharmacy. As drug prices continue to go up, consumers are forced to pay more out of pocket for them, which means this virtual lifeline to affordable medicine has never been more ...Read more -->
Did you know your tax dollars support research that leads to drugs priced so high Americans can’t afford them? We think this is wrong and we urge you to help us speak out about this issue.
RxRights signed on to a letter to the National Institutes of Health (NIH) last week, along with 10 other public ...Read more -->
A recent opinion piece in the New York Times by Kasia Lipska, an endocrinologist from the Yale School of Medicine, takes the three pharmaceutical giants who dominate the U.S. insulin market to task for their shocking price hikes.
Lipska asserts that in the five-year period from 2010 to 2015, “the price of Lantus (made by Sanofi) ...Read more -->
Updated March 11, 2016
An Rx Price Watch report from AARP’s Public Policy Institute that was just released found retail prices for brand name, generic, and specialty prescription drugs widely used by Medicare beneficiaries went up an average of 9.4 percent in 2013 (the general inflation rate was 1.5 percent during that time).
Drug pricing is clearly ...Read more -->
Astronomical drug prices are a serious public health problem. But who’s to blame? Pharmaceutical and insurance industries point fingers at one another. Presidential candidates are talking about the issue. Congress has held hearings to discuss the problem.
Meanwhile, prices aren’t going down. And Americans continue to suffer. It looks like it’s up to you and me ...Read more -->
Martin Skhreli continues to make headlines and garner contempt. The hedge fund manager turned pharma executive who is notorious for raising a drug’s price 5000 percent overnight, was an unresponsive witness at a House Oversight and Government Reform Committee hearing last week.
The hearing was set to discuss methods and reasoning behind recent drug price increases ...Read more -->
This response was submitted to the Star Tribune on 1/26. It’s unclear if it will be published so we are posting it here too.
The January 22 editorial “It’s up to Congress to curb the high costs of prescription drugs” is spot on. It’s time Congress moves “beyond political theater” on this issue. House Democrats held ...Read more -->
Martin Skhreli, the hedge fund manager turned pharma executive who is infamous for raising a drug’s price 5000 percent overnight, is now refusing to cooperate with two Congressional inquiries into drug prices.
Turing Pharmaceuticals CEO Skhreli invoked the Fifth Amendment and refused to provide documents related to pricing subpoenaed by the Senate Special Committee on Aging. ...Read more -->
More than 50 members of Congress are urging the Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to use their authority to bring relief to consumers struggling to pay exorbitant drug prices.
A letter to Secretary of HHS Burwell and NIH Director Collins requests the development of official guidelines to discourage ...Read more -->
RxRights has been working to promote and protect your access to affordable medicine for more than 5 years. Each year, we review our progress, reflect back on lessons learned, and look forward to the future.
We have long warned that unaffordable drug prices amount to a public health crisis in America. Up until this past year, ...Read more -->
By Leigh Purvis
A prominent cancer specialist made headlines when he openly criticized the prices of new cancer drugs. In a speech given before the American Society of Clinical Oncology (ASCO), Leonard Saltz, MD, argued that, rather than value, drug prices are “based on what has come before and what the seller believes the market will ...Read more -->
For more than 5 years, RxRights has been fighting for access to affordable medicine. We nearly shut down after losing a major grant early this year. But many of you stepped up to help. So far, we’ve been able to stay the course because of your donations!
But we could still use some help. One issue ...Read more -->
We launched a campaign earlier this year to pressure insulin manufacturers to do something about the high price of insulin. Many of our supporters have sent messages to Eli Lilly, Novo Nordisk and Sanofi–the three main manufacturers of insulin.
Your messages had a tremendous impact. They opened a dialog with two of the three companies about ...Read more -->
We’re pleased to see that drug prices remain in the spotlight, in terms of news stories and government attention. Last week, the Senate Special Committee on Aging held a bipartisan hearing on drug price increases. House Democrats held a hearing on drug affordability earlier in the month. And the Department of Health and Human Services ...Read more -->
Today is Giving Tuesday, a global day focused around giving back. Please consider making a tax-deductible contribution to RxRights. It’s an opportune time because we have a $5000 match—which means your donation dollars will be doubled. All donations up to $5000 will be matched!
Many thanks to those who already donated! For five years, RxRights has ...Read more -->
The Department of Health and Human Services (HHS) is holding a forum on drug prices on Friday. The agenda for “Innovation, Access, Affordability and Better Health,” includes a discussion about patient access and affordability. The forum aims to “bring together consumers, providers, employers, manufacturers, health insurance issuers, representatives from state and federal government, and other ...Read more -->
It’s National Diabetes Awareness month—a fitting time to give you an update on the action we launched in August related to the high price of insulin.
As you know, we don’t typically focus on a particular medication or disease. But people struggling to afford insulin continue to comment on our 2013 blog post about the drug’s ...Read more -->
As we’ve worked to promote and protect access to affordable medicine over the last five years, getting media attention for the issue has always been a challenge. But we’re pleased to see media attention lately and significant action around the topic of rising drug costs this week. As the costs of specialty, brand name and ...Read more -->
Last month, CEO of Turing Pharmaceuticals Martin Shkreli unwittingly became the face of pharma greed when he raised the price of a medication his company recently acquired 5,455 percent overnight. Daraprim is used to fight toxoplasmosis, which is a serious threat to people with compromised immune systems. It’s not a new drug; the FDA approved ...Read more -->
In May I wrote to let you know about a loss of funding that almost shut us down. A number of you reached into your pockets despite limited finances to help save RxRights—that’s the reason we were able to continue. We’re so thankful for this support! We’re on our way to our funding goal.
With some ...Read more -->
The final rule related to Section 708 of the FDA Safety and Innovation Act has been released and goes into effect on October 15. This rule establishes a process for the seizure and destruction of imported prescription drugs valued at $2500 or less.
To refresh your memory, Congress passed the FDA Safety and Innovation Act (S. ...Read more -->
If you follow the news, you’ve seen lots of press lately about the former hedge fund manager who bought a drug company and jacked the price of a pill from $13.50 to $750 overnight. But, as many of you are well aware, this isn’t the first time such an outrageous increase has occurred.
Lately, we’ve been ...Read more -->
By Sarah Kliff
Daraprim is a small, white tablet that looks a lot like aspirin. It was created in the 1960s and treats a parasitic infection called toxoplasmosis. And last month, Daraprim’s price increased 5,500 percent.
No, that is not a typo: Turing Pharmaceuticals recently acquired Daraprim from another drugmaker. Shortly after, the company raised the price ...Read more -->
Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD) just introduced comprehensive legislation to address the outrageous prices of prescription drugs. The Prescription Drug Affordability Act of 2015 aims to bring down drug prices through a variety of measures.
Though we don’t endorse political candidates, RxRights signed on to support this legislation. You might recall that ...Read more -->
We regularly hear from people who can’t afford the high price of U.S. prescription drugs. Often we point those individuals to legitimate international online pharmacies. Many are able to find dramatic savings from Canadian and other international online pharmacies. But depending on the medication and their unique situation, importation may not be the right solution. ...Read more -->
We were pleased to see a plethora of press last week about a new Kaiser Family Foundation public opinion poll addressing prescription drug prices. The poll powerfully reiterates what we already know: American consumers are fed up with exorbitant drug prices.
Specifically, 72 percent of those polled said drug costs are unreasonable. About one quarter of ...Read more -->
Our latest press release, please consider taking action on behalf of diabetics who can’t afford insulin:
RxRights, a nonprofit group concerned with the high cost of medicine, has launched a campaign to pressure pharmaceutical manufacturers to reduce insulin prices.
“We recently heard from someone who was considering taking insulin formulated for dogs because it was cheaper and ...Read more -->
RxRights doesn’t normally focus on a specific medication or a particular disease. But we wrote an article back in 2013 about the rising cost of insulin. And it is, by far, the most-read blog post we have ever written. Since it continues to garner comments each week from diabetics struggling to afford their needed medication, ...Read more -->
The high price of medicine in the United States is forcing people to go to extreme measures to obtain their life-sustaining medications. We heard a couple of disturbing stories this week that we want to share to illustrate this point.
One person made a comment on our blog post about the price of insulin that really ...Read more -->
We’ve been anxiously watching Congressional action on the Trans-Pacific Partnership (TPP) trade deal, particularly over the past weeks. Yesterday the Senate voted (60 in favor and 38 against) to give President Obama fast-track authority, a temporary and controversial power to negotiate this international treaty with little to no Congressional input.
Now the bill moves to the ...Read more -->
Have you had trouble using a credit card to purchase medications from an international online pharmacy lately? You’re not alone. Unfortunately, this problem won’t be going away any time soon. Companies like Visa and Mastercard have joined the Center for Safe Internet Pharmacies (CSIP), an alliance of organizations that aims to protect people from rogue ...Read more -->
Thanks so much to those of you who stepped up to donate to the cause and sign our petition to support the Safe and Affordable Drugs from Canada Act. Your financial support is directly tied to our ability to keep fighting for affordable medicine. Because of your willingness to take action, we’re up to 4706 ...Read more -->
Here’s our latest press release regarding our petition efforts. Have you signed?
RxRights, a national group concerned with the high cost of medication, is urging consumers to sign a petition to support bills that would legalize the personal importation of authentic prescription medications from Canada.
In January, Senators John McCain (R-AZ) and Amy Klobuchar (D-MN) introduced S.122, ...Read more -->
A major grant RxRights was depending on didn’t come through. This is a major blow—it could shut us down. Unless we manage to raise some funds to continue.
As a small nonprofit program, we already operate frugally and on a modest budget. But if only 20 percent of the people on our email list donated just ...Read more -->
We’ve launched a petition today to support pending legislation to legalize the importation of cheaper prescription drugs from Canada. Click here to sign! And see our press release below:
The prices of some generic medications have skyrocketed in the past year—increasing as much as 1000 percent. Brand name and specialty drug prices are on the rise ...Read more -->
As many of you well know, the prices of some generic medications have been increasing at an alarming rate. Since many Americans rely on the affordability of generics, we have been very concerned by this trend. We’re pleased to report that the federal government will be investigating this matter.
You might recall that we enlisted your ...Read more -->
Imagine spending $30,000 in one year on prescription drugs. That was the reality of RxRights member Joyce Gulseth and her late husband Don. Joyce cared for Don while he suffered through three organ transplants related to diabetes complications. At one point, Don was taking 64 pills each day. The cost of his medications, even with ...Read more -->
An opinion piece on The Hill’s Congress Blog caught our attention last week. “Drug importation is a dangerous idea that won’t die” made a number of claims and misstatements that we felt warranted a response—so we submitted one by way of a DISQUS comment on the original piece.
Well, it’s four days later and our comment ...Read more -->
Maine’s law permitting personal prescription drug importation was overturned last week by a judge who says the federal ban on importation supersedes state law. The Pharmaceutical Research and Manufacturers of America (PhRMA) called the decision a “victory for patients.”
Amy from Maine left a testimonial on our website that counters that sentiment:
“As someone who was told ...Read more -->
Early this month, Lee Graczyk, our lead organizer, was invited to speak at a National Retiree Legislative Network (NLRN) conference in Washington, DC. While there, he also took the opportunity to schedule appointments with policy makers to share RxRights’ message about the need for continued access to affordable medicine. We thought you might like to ...Read more -->
President Obama released his budget proposal last week. We were pleased to see it contains a number of measures related to controlling drug prices, particularly for Medicare enrollees.
Medicare already makes up about 15 percent of the federal budget. The advent of astronomically priced specialty drugs like Sovaldi, a $1000 pill to treat hepatitis C, threatens ...Read more -->
The National Association of Boards of Pharmacy has come out with yet another progress report on their Internet Drug Outlet Identification Program. In it, they justify their control over the .pharmacy Top-Level Domain (TLD) and contend it’s a “public health initiative to help consumers distinguish legitimate online pharmacies from rogue online drug sellers.”
In reality, they’re ...Read more -->
Maine was the first state in the country to enact legislation legalizing personal drug importation, back in October 2013. Maine’s “Act to Facilitate the Personal Importation of Prescription Drugs From International Mail-Order Pharmacies” allows residents to import medication from Canada, the UK, New Zealand, and Australia.
The law has been in place for a year and ...Read more -->
We haven’t had much good news involving American access to affordable medicine lately. Generic drug prices have been spiking, specialty med prices are out of control and the right to import prescription drugs remains in jeopardy. That’s why we were pleasantly surprised by the findings of a new Commonwealth Fund report, which seems to indicate ...Read more -->
As a part of reflecting back on the year, we’ve been gathering some statistics that may interest you. We want to be sure we’re providing you with relevant information. Please let us know in the comments section below what type of stories you’re interested in seeing from RxRights in 2015.
According to our website and social ...Read more -->
It’s hard to believe that another year has come to a close. At RxRights, we consider the year’s end as an opportunity to reflect back and take stock of our accomplishments and lessons learned, and begin constructing a plan for the future.
We’ve seen some tremendous growth in 2014. Our mailing list surged from 59,453 to ...Read more -->
Senator Bernie Sanders and Congressman Elijah Cummings held a Congressional hearing on November 20 regarding the recent, troubling spike in generic prices. In preparation for the hearing, their staff asked RxRights to gather personal stories from those affected by generic drug price hikes. Thank you to those of you who took the time to submit ...Read more -->
Why do prescription drugs cost so much? Ask the pharmaceutical industry and they’ll point to their need to make a profit for shareholders. Or to their colossal research and development costs. Or lately, they’ll blame it on insurance companies. Shifting the blame is a key tactic they have used in justifying the status quo.
That’s why ...Read more -->
The Black Friday and Cyber Monday shopping madness have subsided. Today is #GivingTuesday, a global day geared towards giving back to causes you believe in. On #GivingTuesday, we’re asking you to consider pitching in.
In nearly every Congress for the past 20 years, legislation to allow Americans to import prescription drugs from Canada has been introduced ...Read more -->
Last week’s Subcommittee on Primary Health and Aging hearing on the recent alarming increases in generic drug prices was a step in the right direction. It’s critical to draw the attention of our policy makers to this issue. We commend Senator Bernie Sanders and Representative Elijah Cummings for spearheading this effort and investigating the problem.
Senator ...Read more -->
The Subcommittee on Primary Health and Aging held a hearing on November 20, 2014 regarding skyrocketing generic drug prices. RxRights submitted 188 stories from our supporters for the hearing.
A recording of the hearing and written testimony is available on the Subcommittee website.
Read more -->
Have your generic drug prices gone up lately? If so, we’d like to hear about it.
As Lee Graczyk mentions in an opinion piece that ran yesterday in The Hill’s Congress blog, generic drugs have long offered cash-strapped patients a viable alternative. But a recent analysis found that half of all generic drugs rose in price during ...Read more -->
This opinion piece was originally published on The Hill’s Congress blog, November 12, 2014
Prescription drug prices have reached record levels, putting Americans at risk. U.S. citizens have long had to cope with excessive brand name drug prices and more and more can’t rely on generic drugs being affordable—as generic prices have been spiking dramatically. Increasingly, ...Read more -->
As a nonprofit and nonpartisan organization, RxRights can’t endorse candidates or tell you who to vote for. But if you believe (as we do) that access to affordable medicine is a crucial issue, we can point you to some information that might help you evaluate the candidates.
Open Secrets is a great resource. The website was ...Read more -->
You might recall us asking you to sign a petition a while back opposing the National Association of Boards of Pharmacy (NABP) bid to control the .pharmacy domain. Thank you to all who supported this effort. We gathered a total of 24,349 signatures! Lee Graczyk, lead organizer for RxRights, recently traveled to Los Angeles to ...Read more -->
A September Consumer Reports Best Buy Drugs poll found that the high cost of medicine compels Americans to take unnecessary health risks and forces families to make impossible choices, such as having to decide whether to buy medication or groceries.
Generic drugs have long provided an alternative for cash-strapped consumers. But a recent analysis published by ...Read more -->
We are troubled by the scare tactics used in a recent post on Congress Blog by Jim Dahl, a board member from the group Partnership for Safe Medicine, titled “Stopping the spread of counterfeit drugs and illegal Internet pharmacies.” While it’s true that consumers need to use caution when choosing an online pharmacy, there ARE ...Read more -->
Election season is the perfect opportunity to have your voice heard. The candidates are out there campaigning and listening to constituents. Will you help us bring attention to the need for access to affordable medicine? Together, we can find out where the candidates stand on the issue.
Back in 2005, Dr. Peter Rost, a former Pfizer ...Read more -->
An article about drug importation from Canada appeared in the New York Times last week. Interestingly, it wasn’t in the health or finance section, it appeared in the “fashion & style” section. We were pleased to see this subject getting some attention in popular media and decided to submit a letter to the editor to ...Read more -->
As you probably know, we have a dedicated space on our website where Americans who struggle to afford their prescription drugs can tell their stories. Many of these people import their needed medications from legitimate international online pharmacies saving a great deal of money.
Every now and then, we get compelling messages (see below) from folks ...Read more -->
We believe that all Americans benefit from an Internet that is accessible and open to all. That’s why we’re participating in an Internet action on September 10 to raise awareness about the fight for net neutrality.
Wikipedia defines net neutrality as: “the principle that Internet service providers and governments should treat all data on the Internet ...Read more -->
According to a new government report, the U.S. spent about $3 trillion on healthcare in 2013. It’s predicted that spending will be gradual in the next decade, but it’s still alarming to see how much of our total economy is devoted to healthcare (over 17 percent) considering the number of Americans who struggle to pay ...Read more -->
There have been some interesting developments regarding the take down of online pharmacy domains lately. Over the weekend, the FDA asked easyDNS, a website registrar, to take a pharmacy website down based on reports that someone died after ordering a controlled substance from the site.
We consider this an appropriate response due to the graveness of ...Read more -->
We’ve been rallying our base of supporters in the last months to make some noise to help counter the FDA’s proposed rule to allow for the seizure and destruction of personally imported medicine. Thank you for to those who have taken action! You have sent letters to newspapers, senators, and other government officials—and your efforts ...Read more -->
The pharmaceutical industry has been facing much criticism in the press lately, not just from patients but from legislators, doctors, and the insurance industry too. Although specialty drug prices have been a concern for some time, the new uproar relates to one specific drug—Sovaldi. A 12-week course of treatment in the U.S. for Gilead’s new ...Read more -->
It came to our attention recently, that Marjorie Clifton, the executive director of the not-for-profit Center for Safe Internet Pharmacies was playing pretty fast and loose with a statistic regarding alleged deaths from prescription drugs bought online. We felt obliged to comment on the article and clarify the statistic.
Here’s Lee Graczyk’s comment:
In response to The ...Read more -->
A few weeks ago, we made a public comment on a proposed FDA rule that jeopardizes access to affordable medicine. The rule pertains to section 708 of the FDA Safety and Innovation Act (S. 3187) and would give government officials the authority to destroy an imported drug valued at $2,500 or less. Our comment, as ...Read more -->
Vaccines are a critical, preventative component of public health. For decades, their near-compulsory use in infants and school-aged children has ensured that younger generations of Americans won’t contract and spread serious and even deadly diseases. Vaccines have traditionally been cheap and ubiquitous, but as a shocking New York Times story illustrates, this is no longer ...Read more -->
Your actions to counter the FDA rules regarding Section 708 of Food and Drug Administration Safety and Innovation Act (FDASIA) are gaining traction.
As you may know, the rule would enable government officials to seize and destroy safe imported medicine. We recently wrote about Senator Vitter’s amendment to eliminate funding for enforcement of this rule—which would ...Read more -->
The FDA has proposed a new rule that would allow them to seize and destroy medications imported for personal use from outside of the United States. Consumer and aging rights groups are expressing alarm that the rule will endanger public health.
The proposed rule pertains to section 708 of the FDA Safety and Innovation Act (S. ...Read more -->
We’re pleased to report that Senator Vitter (R-LA) has offered an amendment to the fiscal year 2015 Agriculture Appropriations bill that would prevent implementation of the FDA’s regulation to destroy safe imported medicine! With Independence Day coming up, it’s unclear when the amendment will come up for a vote, but we wanted to keep our ...Read more -->
Can you imagine living in a country where people die, not because treatment isn’t available, but because they can’t afford the high price of medicine? Unfortunately, that alarming future America may be imminent.
That’s why we need your help. As you may know from our previous communications, the FDA is moving forward with a plan to ...Read more -->
The FDA wants to eliminate your ability to import safe and affordable prescription drugs. They have proposed new rules that would give them the right to seize and destroy imported medicine.
The proposed rules pertain to section 708 of the FDA Safety and Innovation Act (S. 3187). More about section 708. The rules would give government ...Read more -->
Lee Graczyk submitted a letter to the editor of the Portland Press Herald today in response to a recent article regarding the lawsuit against Maine’s law to allow citizens to import prescription drugs. We’re not sure if it will be published but wanted to share it with our readers.
I’m writing on behalf of RxRights, a ...Read more -->
A flurry of recent news stories tells the tale of shocking price disparities for the same medication at different pharmacies. The media have been covering price jumps in both generics and brand name drugs. We’ve seen stories from Oklahoma, Minnesota, Texas and Missouri, which illustrates that this isn’t an isolated problem. It appears as though ...Read more -->
If you are like millions of Americans, you (or someone you know) struggle to pay for needed medications. Every day, we hear from people who can’t afford the high price of U.S. prescription drugs. Often we point those individuals to legitimate international online pharmacies—and many are able to find dramatic savings from Canada and abroad. ...Read more -->
The proposed rules regarding section 708 of the FDA Safety and Innovation Act (S. 3187) have been released. This new regulation involves the seizure and destruction of imported medicines valued at $2500 or less, which puts importation from legitimate online pharmacies in serious jeopardy. Find out more about section 708.
We’re posting a link to the ...Read more -->
The National Association of Boards of Pharmacy (NABP) has issued yet another report regarding how online pharmacies pose a threat to public health. At the risk of repeating ourselves, we agree that something needs to be done about the real harm that rogue online pharmacies present. But the fact remains: not all international online pharmacies ...Read more -->
Senator Bernie Sanders of Vermont was in Minneapolis, Minnesota last weekend. Bob Hines, Mature Voices Minnesota board chair, spoke to the Senator about prescription drug importation. We’re pleased to report that Sen. Sanders reaffirmed his longtime support for importation. It’s nice to know we have some support in Congress that never waivers.
Read more -->
We’re pleased to report that our petition opposing the National Association of Boards of Pharmacy’s bid to control .pharmacy (an industry-specific Internet domain) has now reached 21,136 signatures!
Thank you to all who took the time to add their names to the petition! We have you to thank for this success—we couldn’t have done it without ...Read more -->
RxRights has experienced phenomenal growth in the past year. In fact, we more than tripled our email list!
In an effort to better understand our supporters, we have developed a brief survey. Won’t you take 5 minutes out of your day to respond?
Please note: your responses will be anonymous unless you choose to submit your contact ...Read more -->
There are a number of obstacles Americans will face this year related to access to affordable medicine. One of the most troublesome involves Section 708, a portion of the FDA Safety and Innovation Act (S. 3187) passed in 2012.
Section 708 requires the Secretary of Health Human Services (HHS) to establish rules regarding the seizure and destruction of ...Read more -->
We at RxRights have been concerned regarding testimony and discussion at a recent House subcommittee hearing entitled “Counterfeit Drugs: Fighting Illegal Supply Chains.” And we decided it was time to speak up.
We sent a letter to Congressman Tim Murphy (R-PA), chairman of the U.S. House
Energy and Commerce Subcommittee on Oversight and Investigations. We also copied ...Read more -->
This year is rapidly shaping up to be what may be one of the most challenging years in our struggle to ensure that Americans have access to sources of safe, affordable medicine. The ability to continue to buy safe, affordable prescription drugs from reputable and licensed pharmacies outside the U.S. is in particular jeopardy.
The following ...Read more -->
Japan’s Ministry of Health, Labour and Welfare has initiated a criminal probe against Novartis in relation to its marketing of valsartan, a drug used to treat high blood pressure. Apparently, a Novartis employee was involved in clinical trials of the drug without disclosing the company affiliation. Further scrutiny has demonstrated that trial data was manipulated ...Read more -->
Another week, another lawsuit filed against big pharma. Details of a whistleblower complaint initially filed in 2007 against Celgene were released last week. The suit alleges that the company aggressively marketed the drugs Thalomid and Revlimid for unapproved uses, gave doctors kickbacks for prescribing the meds, and knowingly concealed significant drug risks.
The suit was filed ...Read more -->
RxRights initiated a petition back in June regarding our opposition to the National Association of Boards of Pharmacy (NABP) bid to control .pharmacy—a new, industry-specific Internet domain. We continue to gather signatures. You may have noticed that we haven’t had much to report on this topic lately as we wait for the group in charge ...Read more -->
Late last year, a new bill was introduced that would legalize personal drug importation. Some of you may be wondering why we haven’t mentioned this bill in our blog or social media posts. Over the past several months, we worked with the author on language for the bill. But ultimately, we decided not to back ...Read more -->
A new year brings with it opportunity. At RxRights, we like to use the beginning of a new year to reflect. We have been revisiting our 2013 accomplishments and would like to share them with you. We’ll also be working to identify areas for improvement for the year ahead. As always, feel free to contact ...Read more -->
Due to exorbitant drug prices in the U.S., record numbers of Americans are going without their needed medications. Over a million people find relief each year by buying their needed medications online from Canadian and other international online pharmacies. Yet, the National Association of Boards of Pharmacy, the FDA, and much of the popular press ...Read more -->
A pending international treaty could have a huge impact on Internet freedom as well as copyright and patent laws. Yet, most Americans have never even heard of it. The text of this agreement is not publicly available—in fact, our Congress is not even privy to its contents. We are particularly concerned about this treaty because ...Read more -->
With the federal deficit and the Affordable Care Act, health care spending has been under a microscope lately. We at RxRights welcome this renewed scrutiny regarding where our health dollars go. Still, it’s somewhat surprising how regularly instances of serious waste are uncovered. Last week, the investigative journalism group ProPublica released a surprising analysis. Their ...Read more -->
Rogue websites that sell fake and counterfeit prescription drugs are a problem. They jeopardize public health and give legitimate sites providing Americans with authentic, affordable medicines a bad rep. It is in everyone’s interest to eliminate these phonies.
But the recent National Association of Boards of Pharmacy (NABP) report on Internet pharmacies once again goes too ...Read more -->
The New York Times has been running a series of eye-opening articles about the high cost of health care in the U.S. that may resonate with our readers. The series, called “Paying Till it Hurts,” includes pieces that address the high cost of prescription drugs. We wanted to draw your attention to these compelling articles ...Read more -->
Diabetes is a chronic disease that afflicts 25.8 million Americans. Insulin, one of the primary treatments for diabetes, has been around since the 1920s. Yet, somehow the drug is still priced beyond the reach of many Americans. One of our advocates recently left a comment on our Facebook page regarding this problem, which encouraged us ...Read more -->
You know Lee Graczyk as lead organizer of RxRights. But he also serves as director of Mature Voices Minnesota (MVM), a nonprofit group that works to ensure that older adults can live healthy, independent, affordable, and dignified lives in their communities. Early this week, Lee was invited to speak at a press conference held by ...Read more -->
As you may know, a new law took effect in Maine last week that could have a much wider impact on prescription drug pricing. The “Act to Facilitate the Personal Importation of Prescription Drugs From International Mail-Order Pharmacies” allows Maine residents to import medicine from Canada, the UK, New Zealand, and Australia.
We recently sent a ...Read more -->
From the PharmacyChecker.com blog
By Gabriel Levitt and Sam Werbalowsky
This past Monday, we reported that average savings from international online pharmacies are now 87% on popular brand name meds, up from 85% a year ago. As Americans gain access to health insurance through state exchanges under Obamacare, which kicked off yesterday, will there still be a ...Read more -->
A new analysis by the Alliance for a Just Society shows how critical it is to break the stranglehold that big pharmaceutical companies have on Congress.
“Bad Medicine: Pharmaceuticals’ Prescription for PROFITS over PEOPLE” details how the money and influence of Big Pharma have effectively immobilized Congress.
From campaign contributions with strings attached to an army of ...Read more -->
Back in June, we reported about new legislation in Maine that gave consumers the right to import drugs for personal use from Australia, Canada, Northern Ireland, New Zealand, or the United Kingdom. We were thrilled with this precedent, but have to admit that since then, we’ve been waiting for Big Pharma to make their opposing ...Read more -->
A controversial bill was passed in the California Senate last week that could influence future prescription drug affordability in the state and well beyond. The measure passed despite facing opposition from a number of powerful groups, like the Generic Pharmaceutical Association, AARP, and the California Association of Health Plans.
Big biotech companies have been aggressively pushing ...Read more -->
Last month, provisions of a new law went into effect that will shine a spotlight on the financial ties between doctors and drug companies. For years, drug companies have hired doctors to consult, give lectures, and conduct research, sometimes showering docs with money and extravagant gifts in exchange.
With pharma’s kickbacks comes an expectation that docs ...Read more -->
Loyalty cards for supermarkets and chain stores are ubiquitous these days. If you show your card at the checkout, you get a discount or receive coupons for future purchases. Most of us don’t give these cards a second thought. But did you ever stop to consider that each time your card is scanned, that company ...Read more -->
We all know that the pharmaceutical industry wields a considerable amount of power within the U.S. We’ve grown accustomed to the drug lobby’s ability to influence Congressional decisions. And the lengths that Big Pharma goes to in order to protect profits rarely surprise us anymore. But Eli Lilly’s move to sue the Canadian government for ...Read more -->
The unsustainable cost of health care in the United States is regularly blamed on factors like the growing generation of Baby Boomers, the uninsured, or malpractice lawsuits. But it’s clear from a recent Bloomberg story that an untold portion of sky-high health care expenses can be attributed to another reason entirely—fraud and corporate greed.
Ven-A-Care, a ...Read more -->
The National Association of Boards of Pharmacy (NABP) issued another report late last month using their usual scare tactics in an attempt to convince American consumers that all online pharmacies are dangerous (unless vetted by VIPPS, their pharma-funded verification system).
Their accompanying press release doesn’t give American consumers much credit. It paints them as naive and ...Read more -->
By Lee GraczykLead OrganizerRxRights
When I read this week about the latest pharmaceutical industry transgression and fine (Pfizer’s $491M settlement), I was reminded of the children’s iterative ditty, “The Song That Never Ends.” Written and composed by Norman Martin, the song is an infinite-loop motif that repeats the same verse over and over ad nauseaum—until even ...Read more -->
The Secretary of Health and Human Services announced this week that the 6.6 million people with Medicare coverage have saved over $7 billion on prescription drugs due to the new health care law—an average of $1000 per person.
The Affordable Care Act (AKA the ACA or Obamacare) has been highly controversial, and while it’s still early ...Read more -->
As our faithful readers already know, we recently started a petition to oppose the National Association of Boards of Pharmacy’s attempt to control a new Internet domain specifically designated for pharmacies. The NABP opposes personal drug importation and has a habit of lumping legitimate international online pharmacies together with rogue pharmacies. If granted authority over ...Read more -->
Late last month, Maine became the first state in the U.S. to legalize personal drug importation from licensed international pharmacies. Maine’s House and Senate approved the bill, titled: “An Act To Facilitate the Personal Importation of Prescription Drugs from International Mail Order Prescription Pharmacies” with overwhelming, bipartisan support. Since Governor Paul LePage did not veto ...Read more -->
July 3, 2013PharmacyChecker BlogBy Gabriel Levitt
For those of us looking online for safe and affordable medication, it’s very disconcerting to hear about the problem of fake Canadian online pharmacies, or any fake online pharmacy, and the myriad ways they can endanger your health, such as by sending counterfeit or substandard medication or engaging in identity ...Read more -->
RxRights has launched a petition to oppose the National Association of Boards of Pharmacy’s (NABP) bid to control .pharmacy—a new, industry-specific Internet domain.
“A U.S.-based organization with such close ties to the pharmaceutical industry should not be allowed to dictate who gets to participate in this global portal to safe online medicine,” says Lee Graczyk, RxRights ...Read more -->
We’d like to share some exciting news from Maine. Last week the state’s legislature passed a bill to allow mail-order importation from international pharmacies. The bill, “An Act To Facilitate the Licensing of International Mail Order Prescription Pharmacies by the Maine Board of Pharmacy” (LD 171), negates a September 2012 ruling by Maine Attorney ...Read more -->
We’ve gotten word that an old scam is rearing its ugly head again. For a number of years, scammers have been targeting people who purchase prescription drugs online. We wanted to warn our readers again about this fraudulent activity.
Perpetrators of the scam pose as DEA agents. They call unsuspecting victims and threaten to arrest them ...Read more -->
The issue of drug affordability is not going away. If anything, we are seeing further evidence that this public health crisis is getting worse.
Fifty million Americans aged 19-64 did not fill their prescriptions due to cost in 2012. Each day, we hear from Americans who can’t afford their medication. Some of them are older ...Read more -->
Overall drug spending in the U.S. went down last year, according to the IMS Institute for Healthcare Informatics. In stark contrast, specialty drug spending went up 18 percent in 2012, according to Express Scripts.
And this is only the beginning of the specialty drug price sticker shock. As reported by FiercePharma, specialty drug prices are forecast ...Read more -->
There are plenty of statistics out there related to prescription drug prices and spending. One measure that has us particularly concerned is medication nonadherence. That is, when people simply stop taking their medication. When people don’t take their meds as prescribed, we know that it compounds their health problems. It results in additional trips to ...Read more -->
As part of our effort to protect American consumers’ right to safe, affordable prescription drugs, we’re compelled to clarify inaccurate information in a recent press release issued by the National Association of Boards of Pharmacy (NABP): NABP’s Vision for .pharmacy Generic Top-Level Domain Provides a Secure Online Space for Pharmacy Consumers Around the World.
We, too, ...Read more -->
Elmer Brunk and his wife Cynthia saved $13,000 on their prescription drugs in 2012 by importing them from a legitimate Canadian online pharmacy. Elmer recently contacted RxRights because he wanted to share what they have learned with others. “I feel strongly that people need to be able to find affordable drugs and not have to ...Read more -->
A recent analysis by Health Care for America Now indicates that the 11 biggest drug companies made a whopping $711 billion from 2002-2012. And Big Pharma profits got a 34 percent boost in 2006—the year that Medicare Part D was instituted. In addition, big pharmaceutical companies continue questionable tactics, such as pay for delay deals, ...Read more -->
You probably know that we’ve been collecting testimonials from people throughout the United States who are struggling to afford the high price of medication.
To further illustrate our point, we wanted to create some video testimonials, to show that these are real people with real stories. Unfortunately, professional video production is expensive and we didn’t ...Read more -->
The facts about international online pharmacies
Read more -->
The Internet as we know it is about to undergo some big changes, which could negatively affect access to affordable medicine. We’re all familiar with the suffixes .com, .org and .net. For years, the Web has operated with a handful of such generic top-level domains (gTLD). But soon a whole host of new gTLDs will ...Read more -->
The sluggish U.S. economy continues to limp along. And sequestration—with its cuts to programs that assist veterans, older adults and children—is beginning to compound the problem. Clearly, some out-of-the-box thinking is in order.
Senator Ron Wyden (D-OR) has a proposal: start cashing in on publicly funded research discoveries. Sen. Wyden recently wrote to the National ...Read more -->
Express Scripts released its yearly prescription drug trends report this week. The headlines we’ve seen emphasize the good news: spending on commonly used drugs—such as those used to treat high blood pressure and cholesterol—is down for the first time in 20 years.
Now for the bad news: the gap between the price of generic and brand-name ...Read more -->
While spending on direct-to-consumer (DTC) prescription drug advertising has declined in recent years, it still amounted to $2.7 billion last year. Companies with some of the biggest drugs on the market were the top spenders—which seems to indicate that the ads are working.
DTC advertising includes TV and print ads, as well as billboards and radio. ...Read more -->
It’s easy to be pessimistic when reflecting on the sluggish state of our economy, but with the new year comes renewed opportunities and new legislation aimed at expanding access to affordable medicine.
In his State of the Union address, President Obama talked about reducing health care costs by …”changing the way that our government pays for ...Read more -->
In response to news reports citing Bureau of Economic Analysis data that shows a 3.6 percent increase in prescription drug prices in 2012, Lee Graczyk, lead organizer of RxRights, issued the following statement:
“Bureau of Economic Analysis data has confirmed the anecdotal evidence we’ve been hearing from consumers across the country: prescription drug ...Read more -->
The New York Times recently broke the shocking news of how Congress gave $500 million to pharmaceutical giant Amgen by way of a last-minute clause in the “fiscal cliff” bill.
The clause—quietly slipped in during a lame duck session of Congress—allows Amgen to sell its profitable kidney dialysis drug, Sensipar, for two more years without being ...Read more -->
We all know that brand name prescription drugs cost more than generics. For brand names, Americans typically pay 85 percent more. But did you know that pharmaceutical bigwigs pay off their potential competitors to stall generic versions of branded drugs?
This crooked tactic—dubbed “pay-to-delay”—allows big drug companies to squeeze as much profit out of their blockbuster ...Read more -->
We’ve all seen them. Ads for drugs that promise to improve your mood, your sleep, your sex life, or fix any number of other aspects of your health. They are slick and appealing. They show scenarios of carefree consumers living active and happy lives.
Pharmaceutical companies spend obscene amounts of money on these ...Read more -->
December 27, 2012PharmalotBy Ed Silverman
In a move certain to create controversy, the American Psychiatric Association has voted to include bereavement in the definition of major depressive disorder, or MDD, that will be contained in the upcoming version of the Diagnostic and Statistical Manual of Mental Disorders, which will be known as the DSM-5, The Washington ...Read more -->
It’s been another busy year for us at RxRights. The year began with a tremendous legislative victory. By engaging millions of online activists—including RxRights’ supporters—January’s Internet blackout stopped swiftly moving, anti-piracy legislation that threatened prescription drug importation in its tracks.
As a nonprofit group that understands the challenge of organizing on a grassroots level, we were ...Read more -->
Too many Americans are struggling to afford their prescription drugs. RxRights’ goal to protect access to sources of safe and affordable medicine has never been more critical, which is why we are asking our supporters for help.
As the year comes to a close, I want to reiterate how much your support matters. Thanks ...Read more -->
Last week Express Scripts reported that over a recent 12-month period, U.S. prices for commonly used brand named prescription drugs increased by 13.3 percent, six times the rate of inflation. One in five prescriptions sold is a brand name drug.
The Express Scripts data confirms something that we already knew: too many Americans can’t afford their ...Read more -->
We know that more than a million Americans each year import their needed medications from international pharmacies. But we don’t know much about these people. Who are they? And what are their reasons for choosing importation?
We had some theories, but we needed some hard data to back them up. Numbers are more convincing than ...Read more -->
We just launched a new webpage with a U.S. map that features these compelling testimonials. You can click on your state to see real stories from people in your area. Thanks to all of you who contributed!
Be sure to visit the page and share it with others. The map illustrates the dire need for continued ...Read more -->
Another bruising election cycle is coming to a close. We at RxRights are relieved. We’re ready for the plethora of attack ads to be over, for the blue and red election antics to stop, for the ultimate debate to finally be won, and for the results to go quietly into the history books.
No matter your political leanings, we can’t overemphasize how important ...Read more -->
The pharmaceutical industry has been systematically defrauding the government—and consequently, American taxpayers. That’s the conclusion of a new report by consumer advocacy group Public Citizen. The group tallied the penalties paid by drug companies over the last couple of decades at $30 billion.
In late 2010, Public Citizen released a related report that named the pharmaceutical ...Read more -->
We recently learned about an existing drug called Metformin that shows tremendous promise for treating pancreatic and other forms of cancer. But big pharmaceutical companies aren’t interested in exploring its potential.
The drug has been around since the late 1950’s and is widely prescribed for people with type 2 diabetes to help lower blood sugar. Studies ...Read more -->
The Food and Drug Administration (FDA) has launched a new educational campaign aimed at directing consumers towards safe online pharmacies called BeSafeRx. While we fully support the theory behind the effort, we find ourselves frustrated with the FDA once again for refusing to acknowledge that legitimate international online pharmacies exist.
The campaign’s “Know the Signs” webpage ...Read more -->
American senior citizens on fixed incomes, strapped for cash, often must choose between their medications and their mortgages
Read more -->
Two new surveys by Consumer Reports found that an increasing number of Americans are making potentially dangerous health decisions. Some examples of unhealthy methods Americans are using to cope with the weak economy and out of control healthcare costs include: not filling prescriptions, skipping doses of medication, splitting pills without doctor approval, and putting off ...Read more -->
Across the country, local governments are struggling to keep budgets in check despite ever-rising healthcare costs. Frustrated by the lack of help from the federal government, cities and states are searching for creative solutions to the problem. Some see personal drug importation from licensed international pharmacies as a solution.
Last week brought some bad news for ...Read more -->
Americans pay more for prescription drugs than anyone else in the world. People in New Zealand pay about 34 percent of what we pay for commonly prescribed drugs. In 1999 Americans spent an average of $485 for prescription drugs. By 2009 this figure jumped to $956–that’s a 97 percent increase! Check out this informative infographic ...Read more -->
As you may know, RxRights and Roger Bate of the American Enterprise Institute are working together on a survey that will shed some light on questions such as why people buy prescription drugs from international pharmacies. Thank you to those of you who have already participated in the survey!
The survey closes next Monday and ...Read more -->
Thank you to those of you who have signed petition to protect access to imported prescription drugs, especially to those who have persisted despite technical issues with the petition site! Still having trouble? We have posted some tips on our website.
The petition closes on Friday. But we still need more than 17,000 signatures ...Read more -->
RxRights is teaming up with Roger Bate of the American Enterprise Institute to shed some light on questions such as why people buy prescription drugs from international pharmacies. We have agreed to distribute and collect survey data from our supporters regarding this issue. In order for us to make the most effective use of the ...Read more -->
Many of you have been contacting us with questions and concerns regarding the timeline for implementation of Section 708 of the FDA Safety and Innovation Act. The short answer is that we aren’t sure. We can tell you we don’t expect any action before the election—your prescription drug shipments should not immediately be affected.
Rules must ...Read more -->
Section 708 of the new FDA Safety and Innovation Act (S. 3187) gives government agencies the authority to seize and destroy prescription drugs that are imported for personal use.
We are calling on our supporters to let the Obama Administration know how you feel about this unfair regulation.
This provision was clearly crafted by big drug companies ...Read more -->
Clare Caldwell, our Florida field organizer, is working to raise access to affordable medication to the level of a serious campaign issue in Florida. We’re pleased to report that she had some success this week during a candidate forum in congressional district 19.
“All it takes is someone to ask the question,” says Clare. The question ...Read more -->
Despite our best efforts, Congress passed the FDA Safety and Innovation Act (S. 3187) with Section 708 intact. Earlier this week, President Obama signed the bill into law.
Section 708 changes prescription drug importation as we know it. This new provision gives the government the authority to destroy personally imported drugs at their point of entry.
For ...Read more -->
We were pleased to see some news coverage out of Minnesota yesterday that illustrates how individuals who depend on importation may be impacted by the legislation. The news video features Lee Graczyk, our lead organizer, and Rico Anderson a longtime RxRights supporter who imports his prescription drugs. Rico saves over $600 each month by ordering ...Read more -->
July 6, 2012PharmacyChecker.com
A new study, reviewed in Medpage Today, finds that seniors falling into the Medicare Part D prescription drug coverage gap, often referred to as the “doughnut hole,” reduced the number of monthly anti-depressant prescriptions they filled by 12.1% compared to those with full coverage. In 2012, Part D plans share drug costs with ...Read more -->
Coalition urges White House to Veto FDA reauthorization bill due to provision eliminating personal importation of medicines
Read more -->
On Monday, you answered our call to action in a nearly unprecedented manner. Within hours of our email, thousands of letters had been sent to senators all throughout the nation. Still, the Senate passed the final version of the FDA Safety and Innovation Act last night and it is headed to the President’s desk.
We are ...Read more -->
Despite our best efforts, the House of Representatives passed the reworked FDA reauthorization bill (S. 3187/H.R. 5651) last week. Now the bill is moving on to the Senate–set for a vote late today. We need a groundswell of importation supporters to help us get the Senate’s attention now!
The secrecy with which the FDA reauthorization bill ...Read more -->
As we feared, this harmful language has made it into the final legislation (the dollar amount merely changed to $2500) and some additional language was included to provide for rule making authority.
Over the last week, we’ve been waiting to find out who the conferees are so that we could alert ...Read more -->
Lee Graczyk felt compelled to respond to a recent New York Times article. Regardless of whether or not the newspaper decides to print his letter, we wanted to share it with our readers.
It has been disheartening to learn about the White House’s backroom negotiations with the pharmaceutical industry. Especially upsetting is the fact that ...Read more -->
Last week, Republican members of the House Energy and Commerce Committee released email documentation that proves what we suspected all along—top White House officials engaged in secret negotiations with PhRMA back in 2009 in order to secure the drug lobby’s help to secure passage of the Affordable Care Act (ACA).
To be clear, these sorts of ...Read more -->
Our ability to import prescription drugs is under attack yet again. Recently, the House Energy and Commerce Committee unanimously approved H.R.5651, the Food and Drug Administration Reform Act. What most people don’t realize, is that a provision buried in this bill’s 294 pages would jeopardize the right of Americans to import affordable ...Read more -->
Lee Graczyk, lead organizer of RxRights, recently submitted a response to the May 25 Wall Street Journal piece, “Senate Backs Broader Fees From Firms to Fund FDA.” We hope it gets printed, but if not, we wanted to at least share it with our readers.
I am outraged that the McCain amendment to Food and Drug ...Read more -->
The McCain Amendment to allow drug importation from Canadian online pharmacies was put to a vote by the Senate this afternoon (as part of S.3187, Food and Drug Administration Safety and Innovation Act). Unfortunately, it failed to pass in a vote of 43-54.
Senators Grassley and Snowe were among those to express their fervent support for ...Read more -->
Last week, we asked you to show support for Senator McCain’s amendment to allow drug importation from Canada as a part of the Food and Drug Administration (FDA) Safety and Innovation Act (S. 3187). Since then, a special interest group with close ties to big pharma started an opposition campaign.
Yesterday, the ...Read more -->
We just got word that Senator John McCain plans to introduce an amendment to the Food and Drug Administration act reauthorization (S. 3187) to allow prescription drug importation from Canadian online pharmacies. Please join us in speaking out to support his action.
Tens of thousands of Americans already rely on the virtual lifeline to medicine provided ...Read more -->
We recently told you about the amendment that Senator John McCain (R-AZ) introduced to allow prescription drug importation from Canadian online pharmacies during a reauthorization of the Food and Drug Administration Safety and Innovation Act.
Unfortunately, the amendment, co-sponsored by Senator Al Franken (D-MN), didn’t make it past the Senate Committee on Health, Education, Labor ...Read more -->
Senator John McCain (R-AZ) introduced an amendment to allow prescription drug importation from Canadian online pharmacies on Wednesday during a reauthorization of the Food and Drug Administration Safety and Innovation Act.
Unfortunately, the amendment, co-sponsored by Senator Al Franken (D-MN), didn’t make it past the Senate Committee on Health, Education, Labor & Pensions. It was ...Read more -->
For some time now, the Food and Drug Administration (FDA) has tried to dissuade consumers from buying prescription drugs from international online pharmacies. That’s why we were gratified to see the findings of a recent National Bureau of Economic Research paper. The study confirms RxRights’ longstanding position that drug importation through verified online pharmacies is ...Read more -->
A 2005 study sponsored by Kaiser Family Foundation, Harvard School of Public Health, and USA Today found that 44% of American households with an asthma sufferer are unable to follow prescribed treatments due to cost. According to the U.S. Centers for Disease Control and Prevention, 1.7 million Americans went to emergency rooms ...Read more -->
PharmacyChecker.comBy Gabriel Levitt
As reported in DigitalJournal this past Wednesday, at a press conference in Keene, NH, Congressman Ron Paul (TX-14), Republican candidate for president, accused the pharmaceutical industry and the FDA of being in “bed together.” He derided their arrangement, characterized by a revolving door of people repeatedly switching jobs back and forth ...Read more -->
PharmacyChecker.comBy Gabriel Levitt and Sam Werbalowsky
Some pharmaceutical industry folks, and their political allies, like to make the point that our nation’s seniors no longer need access to lower cost foreign medication because they now have new and improved Medicare drug plans. But a new report by IMS indicates that drug costs are having a negative ...Read more -->
The AARP’s Public Policy Institute released a research report last month that caused quite a stir. The study found a 26 percent increase in retail prices for the prescription drugs most widely used by older adults from 2005-2009. This is double the rate of inflation over that period.
Not surprisingly, the Pharmaceutical Research and Manufacturers of ...Read more -->
A study was released today by the National Bureau of Economic Research titled “Unveiling the Mystery of Online Pharmacies: An Audit Study.” This authoritative study confirms what we have known all along: personal drug importation through legitimate Canadian and other international online pharmacies is a safe, money-saving option for Americans.
More than a million Americans — ...Read more -->
Pfizer’s new head honcho brought home $25 million in compensation last year. This represents a 44 percent increase over the previous year for Ian Read, a Pfizer veteran who rose to the rank of CEO in late 2010.
What justifies Read’s extraordinary pay bump? He’s developed a new way to squeeze money out of drugs going ...Read more -->
PharmacyChecker.comBy Gabriel Levitt and Sam Werbalowsky
There is a drug affordability crisis in America. As we’ve reported, in 2010 48 million adults did not fill a prescription due to high drug costs. Perhaps surprisingly, in addition to millions of uninsured Americans, many Americans with insurance forgo prescription medication due to cost. Such insured ...Read more -->
Earlier this year we disseminated a survey. We asked you, our readers, to share some information about yourselves with us. Thanks so much to those of you who participated in the survey. There were 1,667 of you!
The survey responses will inform our organization’s future direction. The information gleaned will help us to ...Read more -->
We all breathed a sigh of relief when the Senate and House decided to defer action on the Protect Intellectual Property Act (PIPA) and the Stop Online Piracy Act (SOPA). Unfortunately, they’re at it again.
Another pair of bills (H.R. 4095/S. 2002) has cropped up that, in the spirit of SOPA and PIPA, threatens reputable online ...Read more -->
During the panel discussions, a retired pastor, Delores McCabe, brought focus to the high cost of prescription medication. As reported in the Philadelphia Inquirer:
There has got to be something we can do above the Affordable Care Act that does something about an industry that is immoral,” said, drawing applause from ...Read more -->
The Federal Trade Commission (FTC) is now considering whether to allow Express Scripts and Medco Health Solutions (two pharmacy benefit managers) to merge. Community pharmacists, consumer rights groups and the attorney generals of 25 states oppose the merger, saying that it will negatively influence patient care and drive up prescription drug costs.
We’ve written before about ...Read more -->
President Obama just released next year’s budget proposal and it has already sparked fierce criticism from the pharmaceutical industry. That’s because the plan would require Big Pharma to give an additional $156 billion in drug rebates over the next decade.
You may remember that the pharmaceutical industry already agreed to give $80 billion in discounts and ...Read more -->
PharmacyChecker.comBy Gabriel Levitt
During a recent campaign appearance in front of a Tea Party crowd, as reported by ABC News, Republican presidential candidate Rick Santorum told a mother and her sick son that high drug costs are fair because they are determined by free market forces. It appears that Mr. Santorum doesn’t understand ...Read more -->
A good article in the Huffington Post this week got our attention. “How Drug Companies Game Washington” outlines the pharmaceutical industry’s tremendous political power. The article is part of a weeklong series that critically examines the influence of special interests on politics.
It’s a timely series. Approval for the performance of Congress is at an all ...Read more -->
ABC News ran an article about SOPA’s role in shutting down illegal online pharmacies yesterday. The piece caught our attention because it doesn’t acknowledge the fact that the proposed anti-piracy legislation would use a shotgun approach to target ALL non-US pharmacy websites, regardless of their legitimacy or value to US consumers.
While we agree that American ...Read more -->
If you haven’t already completed the RxRights survey, we’d like to ask you to please take a few minutes out of your busy day to do so.
The better we know you and your concerns, the better we can tailor our messages and actions to engage you and others around the country. The more ...Read more -->
You did it! You stopped SOPA and PIPA in their tracks. You delivered a wake up call to Congress! If ever I doubted the power of the people, I stand corrected now. For weeks it has looked as if the PROTECT IP Act (PIPA) and Stop Online Piracy Act (SOPA) would fast ...Read more -->
Opposition to the Stop Online Piracy Act (SOPA) and the PROTECT IP Act (PIPA)–which both threaten the right to import safe and affordable medicine–continues to mount. It’s looking like anti-piracy legislation could be a hot-button issue in this election year, but the situation continues to change and evolve.
The film, TV and music industries have already ...Read more -->
Senator Amy Klobuchar (MN) held a panel discussion on drug shortages last Thursday at Fairview Southdale Hospital in Edina, MN. RxRights’ staff were invited to attend the event.
At the event, Sen. Klobuchar charged that the pharmaceutical industry is limiting production of low-profit medicines and sometimes even paying generic drug manufacturers to keep cheap alternatives off ...Read more -->
We at RxRights were heartened by our readers’ dedication to protecting access to safe and affordable medicine in 2011. We asked you to take action and speak out–and you did! Since you listened to us, now we want to start the year off right by listening to you.
Please take a few minutes out of ...Read more -->
Lee Graczyk, RxRights lead organizer, felt compelled to respond to a recent Washington Post editorial about the problem of Internet piracy and the legislation that has been crafted to address it. Though we have not had much luck getting the Post to publish Lee’s responses in the past, he continues to try, and wanted ...Read more -->
It’s hard to believe that a new year is already about to begin. In the year 2011, the right to import safe and affordable prescription drugs has been threatened like never before. As a result, it has been a busy year for RxRights. Though the threats are still very much alive, we ...Read more -->
The House Judiciary Committee just held a mark up hearing on the Stop Online Piracy Act (SOPA). As we’ve been cautioning for a while, this bill is dangerous for a number of reasons. Our readers need to be aware of this bill because it would cut off American access to legitimate international online pharmacies.
If you ...Read more -->
December 16, 2011PharmacyChecker.comBy Margaret Rode
Two years ago, ABC News ran a segment (What Would You Do?) that showed Americans going out of their way to help strangers who could not afford their medication. Actors visited local pharmacies pretending they could not afford to pay for their much-needed prescription drugs – something ...Read more -->
It looks like the House Judiciary Committee will give the public a chance to watch the Stop Online Piracy Act (SOPA) markup live via webcast tomorrow morning at 10:00 a.m.
You can bet that we’ll be watching tomorrow. We encourage you to do so too. To tune in, go to their site and click on the ...Read more -->
Adapted from the December 13, 2011 RxRights e-newsletter
It appears that Congress is hell-bent on fast tracking the legislation we’ve been warning you about (SOPA and PROTECT IP). If these proposals prevail, “we the people” lose and Big Pharma wins–big time.
The House Judiciary Committee will be marking up (amending) SOPA on Thursday, December 15 at 10:00 ...Read more -->
Since the Stop Online Piracy Act, or SOPA, is being marked up (amended) by the House Judiciary Committee on Thursday, we’d like to take an opportunity to point some of the bill’s major flaws–and there are many!
First of all, the bill has an overly broad–rather than ...Read more -->
The Occupy Wall Street (OWS) movement, whether you support it or not, has helped to raise some important questions lately about corporate greed. The pharmaceutical industry, though not directly targeted by OWS, has consistently put profits before people, just as the financial industry has. A prime example of this is pharma’s monopoly on life-saving HIV/AIDS ...Read more -->
By Gabriel LevittPharmacyChecker.com
A bill was introduced in the House of Representatives last week that would make repeat counterfeit drug offenders subject to 20-year maximum jail-terms with $4 million fines for individuals and $10 million if the defendant is an entity. PharmacyChecker.com applauds the introduction of H.R.3468, Counterfeit Drug Penalty Act of 2011, as we believe, ...Read more -->
Earlier this week, we asked our subscribers to take action against H.R.3261, the E-PARASITE Act (also known as the Stop Online Piracy Act or SOPA) by signing a petition on the White House website.
Thanks to your overwhelming response, we helped the petition to meet and even surpass its goal! When we sent the message, the ...Read more -->
In response to today’s House Judiciary Committee hearing on H.R. 3261, the Stop Online Piracy Act (SOPA), Lee Graczyk, lead organizer of RxRights, issued the following statement:
“This hearing painted an incomplete picture of SOPA as it relates to drug importation. This does an injustice to legislators and American consumers who deserve a clearer understanding of ...Read more -->
We were pleased to see that this guest column from Lee Graczyk about SOPA was posted on Techdirt today.
The House Judiciary Committee today is holding a hearing to examine the Stop Online Piracy Act (SOPA), a bill that proposes to address online copyright and trademark infringement by denying services to registrants, owners or operators ...Read more -->
Here’s a great blog post about SOPA’s potential impact on public health from RxRights Coalition member Dan Hines, the publisher of a series of leading informational websites for an aging America.
The law of unintended consequences is a warning that an intervention in a complex system tends to create unanticipated and ...Read more -->
The House of Representatives just introduced H.R.3261, the E-PARASITE Act (also known as the Stop Online Piracy Act or SOPA). This is the House counterpart to the Senate’s PROTECT IP Act (the bill we’ve been warning you about for months) but it’s even more insidious.
SOPA is touted as a way to protect intellectual property, but ...Read more -->
RxRights Leader Organizer Lee Graczyk was recently interviewed by WINK News Now, the CBS affiliate in Fort Myers, Florida, about how pending legislation could take away Americans’ right to order prescription drugs from Canada and other international pharmacies.
In the piece, 89-year-old Mary Miller explains that she purchases a ...Read more -->
Last week we issued a press statement regarding the Stop Online Piracy Act (SOPA). This bill, which is informally referred to as the E-Parasite Act, was just introduced in the House and it threatens American access to safe, affordable medicine.
Like the PROTECT IP Act (the Senate version of the anti-piracy bill) SOPA overgeneralizes when it ...Read more -->
Lee Graczyk, lead organizer of RxRights, issued the following press statement in response to new legislation introduced in the House that threatens American access to safe, affordable medicine.
“It is imperative that Congress recognize the difference between ‘rogue’ versus ‘real’ online pharmacies. Recently introduced legislation in the House of Representatives, the Stop Online Piracy Act (SOPA), ...Read more -->
Last week, we blogged about a Consumer Reports article that caused us concern because it dismissed prescription drug importation as an affordable alternative for Americans struggling with the high cost of their needed medicines. This week we revisit that topic with a blog post from a member of the RxRights Coalition.
Citing what he describes as ...Read more -->
We were disappointed to see this biased article by Consumer Reports this week that warns American consumers who are having trouble affording their needed medications to avoid international online pharmacies. They further advise patients to “switch to generics whenever possible, look for discount programs, and ask your doctor or pharmacist about other ways ...Read more -->
House Democrats are asking the debt “super committee” to allow Medicare to negotiate prescription drug prices. We at RxRights are in support of this common sense plan that would save an estimated $156 billion over 10 years.
Letting Medicare use its bulk purchasing power to negotiate prices with drug companies is not a novel idea. The ...Read more -->
We’d like to commend RxRights member, the Canadian International Pharmacy Association (CIPA), for its efforts to protect consumers against rogue online pharmacies. CIPA today announced it is taking action against rogue internet pharmacies wrongfully displaying the CIPA certification seal on unapproved websites.
As the official accrediting organization for all online pharmacy advertisements on Google Canada, Yahoo! ...Read more -->
Sometimes writing to your representatives does make an impact! Brenda Frese, mother of a 3-year-old with leukemia, wrote to Representative Elijah Cummings (D-MD) about shortages of Cytarabine, a critical drug in her son’s treatment that is now in short supply. We’re pleased to report that Cummings was moved by her story and decided to investigate.
The ...Read more -->
October 5, 2011PharmalotBy Ed Silverman
More than a dozen drugmakers have been named in a whistleblower lawsuit that charges they concocted various schemes to underpay rebates to numerous state Medicaid programs over the past seven years. And the complaint was filed by the former head of a major trade group that represents healthcare products distributors.
The lawsuit ...Read more -->
We at RxRights were pleased to see this recent editorial in The Free Press (Mankato, MN) in support of prescription drug importation. Lee Graczyk wrote and submitted a response to the piece and we decided to share it with our readers here:
I’m writing in response to your September 25, 2011 editorial, “Both parties restrain ...Read more -->
When times are tough, people have to skimp and save. It’s only common sense that this would extend to health care. Nearly half of those surveyed admitted postponing doctor’s visits, medical procedures or tests due to costs. Of these people, 28 percent endangered their health by not filling prescriptions, skipping ...Read more -->
We hear every day from people who use international pharmacies. They are people you know: your friends, your spouse, your parents, your grandmother, your brother and your child. They are people who are simply trying to maintain their health and balance their budgets at the same time.
These stories need to be told–and heard. They are ...Read more -->
Lee Graczyk, lead organizer of RxRights, just issued the following statement on behalf of U.S. seniors fighting the high cost of pharmaceuticals through drug importation:
Congress needs to exercise common sense and recognize that personal drug importation from legitimate, licensed pharmacies is a necessity for millions of Americans today.
From the pending PROTECT IP Act to the ...Read more -->
If you have been paying attention lately to the news, you’ll know that the United States is facing an unprecedented shortage of live-saving prescription drugs. Almost every hospital recently surveyed by the American Hospital Association reported being short of one or more drugs in the previous six months. Nearly half of them reported shortages on ...Read more -->
PharmacyChecker.com blog August 31, 2011 By Gabriel Levitt and Margaret Rode
A new report by the Commonwealth Fund, from their 2010 Biennial Health Insurance Survey, shows that 48 million Americans, ages 19-64, did not fill a prescription due to cost in 2010, up from 29 million in 2001 – a 66% increase. The ...Read more -->
RxRights recently made a special effort to reach out to our Oregon supporters. We asked them to join us in sending a “thank you” message to Senator Ron Wyden (OR). Senator Wyden has been single-handedly blocking the PROTECT IP Act, which poses a threat to continued access to safe and affordable medicine ...Read more -->
The PROTECT IP Act threatens American access to safe and affordable prescription drugs from trusted Canadian and other international pharmacies. For this reason, RxRights has been speaking out against this bill over the past months. We’ve also asked our supporters to contact President Obama and Congress to voice their support for continued access to prescription ...Read more -->
It was announced yesterday that Google has settled the U.S. Justice Department’s pharmacy ad probe, Lee Graczyk, lead organizer of RxRights, issued a statement in response:
It is imperative to make the distinction that not all Canadian pharmacies are dangerous rogue sites. There are licensed, legitimate Canadian and other international pharmacies that Americans rely on to ...Read more -->
Our friends at PharmacyChecker made a blog post this week that we wanted to pass along to our readers. You can read the full text below or on their website.
A recent article in The Muskegon Chronicle warns of a new scam against consumers who buy prescription drugs online.
The Chronicle reports:
Some people who bought ...Read more -->
Lee Graczyk, lead organizer of RxRights, issued the following press statement today on behalf of U.S. seniors fighting the high cost of pharmaceuticals.
“More than 38 million senior citizens live on fixed incomes in the U.S. During these difficult economic times, ...Read more -->
PharmacyChecker.com August 10, 2011By Margaret Rode
Besides the obvious – access to cheap generic alternatives for once exorbitantly priced prescriptions – this year’s patent expirations on blockbuster brand-name drugs means even more good news for American consumers. A U.S. News and World Report article suggests the Patent Cliff as one of the reasons for the forecasted ...Read more -->
The Partnership for Safe Medicines recently issued a public health alert about online pharmacies selling “non-FDA approved” medicines. This group (whose executive director has a high-ranking position with the Pharmaceutical Research and Manufacturers of America) has released a flurry of similar news items this week that seem to be geared towards scaring consumers away from ...Read more -->
Many of you have recently written and called us to express your opinions and outage at the high cost of medicine in the U.S. in response to our campaign for safe and affordable medicine.
Thank you for sharing your thoughts and stories with us! Some of these stories are so compelling that we decided to share ...Read more -->
A few months back, the Pew Charitable Trusts hosted a conference that put a spotlight on the safety of the U.S. prescription drug supply, which relies heavily on sourcing active ingredients from developing countries like China and India.
As we mentioned in a previous post, we are in full support of the conference’s goal to prevent ...Read more -->
Pharmaceutical companies spend more on marketing than they do on research and development. The drug industry spends thousands of dollars per physician each year carefully targeting their pitches, directly marketing to doctors and trying to influence what is prescribed.
They go to this trouble because it is extremely profitable for them. Research has shown that if ...Read more -->
Pharmacy Benefit Managers (PBMs) have been in the news a lot lately. PBMs are companies that have sprung up to help employers and insurance companies administer their prescription drug benefits. In theory, PBMs help control drug costs because they can purchase in bulk and are able to negotiate prices with big pharmaceutical companies. In practice, ...Read more -->
Our friends at PharmacyChecker.com recently submitted some suggested revisions to the FDA regarding communications and policy pertaining to online pharmacies and personal drug importation. We thought our readers might be interested in these comments. The following article originally appeared on the PharmacyChecker.com blog.
July 1, 2011By Margaret RodePharmacyChecker.com
Per the FDA’s invitation for regulation reviews and comments ...Read more -->
The Supreme Court decided last week that corporations’ First Amendment rights take precedence over the privacy rights of consumers.
The case was Sorrell v. IMS Health Inc., and the decision means that pharmaceutical companies will continue to have access to prescription data, which allows pharmaceutical representatives to carefully target their drug marketing efforts to doctors. We’ve ...Read more -->
Effecting change is hard work, especially when you are up against powerful opponents like government and industry. It’s far too easy to get frustrated and bogged down when change doesn’t happen fast enough, but perseverance is key. And so is perspective. That’s why the RxRights staff decided to sit down recently to consider how far ...Read more -->
Prescription drug safety has been in the news quite a bit lately. A jury just awarded $625,000 to the estate of a man who died after receiving doses of a contaminated prescription drug.
The drug in question was heparin, a blood thinner made by Baxter International. A few years back, dosages of heparin sickened hundreds of ...Read more -->
Safe and affordable prescription drug importation is facing some serious threats lately. To counteract these threats, we’ve been ramping up our outreach efforts and looking for different ways to spread the RxRights message to the public.
Coalition leader Lee Graczyk recently completed a radio interview tour. He completed 11 interviews in various parts of the U.S. ...Read more -->
By Gabriel Levitt, Vice President, PharmacyChecker.comView original article on the PharmacyChecker blog
Last Thursday, the Senate Judiciary Committee unanimously passed S. 968, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011, also known as the Protect IP Act. Its passage represents a real threat to Americans’ access to safe and ...Read more -->
We’ve learned that the Senate Judiciary Committee is meeting on Thursday morning, May 26, to discuss S.968, the Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 (PROTECT IP Act).
As we’ve indicated in our previous posting, this bill seriously threatens the right of Americans to access affordable prescrption drugs ...Read more -->
Senator Patrick Leahy has just introduced a new Internet censorship bill that could cut off Americans’ right to access to safe and affordable medications from international online pharmacies.
The White House caused us great concern last year when they supported Leahy’s previous version of the bill (COICA). But this new version—called the Preventing Real Online Threats ...Read more -->
Google is reportedly setting aside $500 million to resolve a case with the Justice Department alleging that the company cashed in—to the tune of hundreds of millions—on paid ads from rogue online pharmacies.
In the aftermath of Google’s settlement, RxRights is concerned about a blanket backlash against all online pharmacies. Unlicensed, rogue pharmacies are vastly different ...Read more -->
Late last month, as part of its Internet Drug Outlet Identification Program, the National Association of Boards of Pharmacy (NABP) released a new report that claims that 96 percent of the online pharmacies they reviewed are out of compliance with established U.S. laws and standards. All of these websites are identified on a “Not Recommended ...Read more -->
The Supreme Court heard arguments last week about whether data mining companies should have the right to compile and sell information about what drugs doctors are prescribing to pharmaceutical companies for use in drug marketing (Sorrell v. IMS Health, 10-779).
Pharmaceutical companies spend billions of dollars on marketing each year—even more than they spend on research ...Read more -->
We came across an interesting article last week about how big pharmaceutical companies use direct to consumer (DTC) advertising (mainly via drug ads on TV) to increase their drug sales.
Essentially, DTC drug advertising is a means of hoodwinking the public into demanding drugs they don’t need. The U.S. is one of only two countries (the ...Read more -->
The AP just ran a story about the 65 percent increase that Richard Clark, Merck’s former CEO, got in compensation last year. Most of us can’t even imagine such a huge pay hike. With the U.S. economy in shambles and Americans struggling to pay for their prescriptions, this drug company’s CEO received a total of ...Read more -->
Countless Americans like you can’t afford their needed medications. Millions of Americans have found a safe and affordable alternative–they import their prescription drugs through legitimate Canadian and international online pharmacies.
But this virtual lifeline is in jeopardy. Misguided efforts by Congress and officials in the White House could take away the ability to order medications online–even ...Read more -->
There has been a lot of press lately about the rising cost of pharmaceuticals. And we at RxRights have been telling you over and over how millions of Americans are struggling to afford the exorbitant cost of their needed medications. But it’s rare to see the individual human faces behind this public health crisis.
That’s why ...Read more -->
We’ve been closely monitoring hearings and press related to the Combating Online Infringement and Counterfeits Act (COICA), which was introduced by Senator Patrick Leahy last year. This legislation could have grave implications for safe and affordable online drug importation.
COICA was quickly approved by the Senate Judiciary Committee last year and was headed to a full ...Read more -->
When drug companies spend billions of dollars on marketing each year, they obviously don’t have public health in mind. This excessive spending contributes to the ever-rising cost of prescription drugs.
In addition, top pharmaceutical companies have been known to use aggressive and questionable tactics to promote specific name brand drugs.
We recently wrote about the kickbacks doctors ...Read more -->
A new study by the Mayo Clinic further illustrates the public health risk created by the outrageous price of prescription drugs.
Seniors with a history of heart failure were surveyed for the study. Almost half of the 209 patients said they had stopped taking their medication or had not filled a prescription because of cost. Also, ...Read more -->
The AARP pleasantly surprised us this week by endorsing the Pharmaceutical Market Access and Drug Safety Act of 2011—otherwise known as the Stabenow/Snowe reimportation bill.
The legislation is co-sponsored by Sens. Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) and would provide legal access to safe and affordable drugs from abroad. Currently, the FDA allows for the ...Read more -->
We at RxRights are disheartened at the recent Supreme Court ruling in favor of Big Pharma and against the poor.
Back in January, we told you how big pharmaceutical companies were being sued for overcharging hospitals and clinics designed to help the less fortunate for prescription drugs—despite negotiated caps on prices.
We commend Santa Clara and ...Read more -->
We recently told you about Makena, a preemie prevention drug that went from $15 to $1500 per dose overnight.
There’s a good article in the Washington Post today with some more background about the drug and the FDA approval process. There has been a great deal of criticism in the news lately about this situation. As ...Read more -->
Each year, doctors receive millions of dollars from big pharmaceutical companies. In exchange, the doctors effectively become drug pushers—by promoting particular, name brand prescription drugs to their patients.
Kickbacks can range from small tokens like pens and free lunches to extravagant gifts and even cash. As recently reported in the LA Times, Bristol-Myers Squibb is being ...Read more -->
The recent CBS 60 Minutes piece on the dangers of counterfeit drugs being sent into this country clearly identified the risks to our nation’s health created by those operations, which are illegal, even in their own countries.
It was encouraging that the program recognized that:
there are legitimate sources of prescription drugs beyond our borders from countries ...Read more -->
On Monday and Tuesday Mar. 14-15, the Pew Health Group brought together members of the drug industry, policymakers, regulators and consumers to tackle key questions about overseas drug manufacture, distribution and safety.
Among the presenters was Roger Bate, of the American Enterprise Institute, whose research on the safety of drug importation we have referenced here before.
More ...Read more -->
When pharmaceutical companies are given free reign, people are forced to pay outrageous prices for prescription drugs. We recently learned about a shocking increase in the price of a drug that prevents premature births. This week, the drug’s price will exponentially increase from $15 per injection to an astonishing $1500 per dose!
Why is such an ...Read more -->
The price of prescription drugs in the United States has skyrocketed in recent years. This is especially apparent when you look at widely used, name-brand drugs. An AARP study from last summer indicated a shocking 41 percent increase in the price of the top 207, name-brand drugs from 2004-2009.
Has your salary or pension ever increased ...Read more -->
Like a spring perennial, the “Pharmaceutical Market Access and Drug Safety Act” has been reintroduced in Congress. You might recall this legislation from the 2005, 2007 and 2009 sessions. It was formerly known as the Dorgan/Snowe bill, but now it’s the Stabenow/Snowe bill (S.319).
This iteration has been mercifully reduced from 35 plus pages to 11 ...Read more -->
We recently told you about a Senate Judiciary Committee hearing, “Targeting Websites Dedicated To Stealing American Intellectual Property.” The February 16 hearing addressed the Combating Online Infringement and Counterfeits Act (COICA) introduced by Senator Patrick Leahy last year.
Witnesses from the companies like Visa and Verizon testified at the hearing, as well as a witness from ...Read more -->
Wednesday morning, the Senate Judiciary Committee is holding a hearing relating to Senator Leahy’s Combating Online Infringements and Counterfeits Act (COICA). In its current format, this bill could have grave implications for Americans who rely on drug reimportation as a means to access safe and affordable prescription drugs.
For those of you who are unfamiliar with ...Read more -->
Keeping up with legislative initiatives can be a daunting task. A recent review of Congressional action related to prescriptions and drug policy showed 47 Federal pieces of legislation pending. RxRights is monitoring this legislation. We’ve compiled a snapshot here of some of the more pertinent legislation as it relates to our cause.
S 3804: The Combatting ...Read more -->
We’ve been hearing a lot lately in the press about whistleblower cases against big pharmaceutical companies. But we were surprised to learn this week that the Department of Justice is set to take the lead in a group of lawsuits against Abbott Laboratories.
The lawsuits stem from Abbott’s off-label promotion of Depakote, a drug used to ...Read more -->
The FDA issued a warning last month about an extortion scheme largely targeting people who have used the Internet to purchase their prescription drugs. Victims received phone calls from FDA agent impersonators using scare tactics in order to coerce them into paying phony fines.
In light of this scam, we at RxRights wanted to remind our ...Read more -->
A recent article in The Hill’s Congress Blog takes a critical look at the proposed Combating Online Infringement and Counterfeits Act (COICA). We applaud the Administration’s efforts to crack down on drug counterfeiters and those among them that offer such products on the Internet. These pirates should be made to walk the plank—as they endanger ...Read more -->
President Obama made some statements late last week in a YouTube interview that we at RxRights found both surprising and heartening. He proposed two solutions to the problem of overpriced prescription drugs: giving the government the ability to negotiate prices with drug companies and prescription drug reimportation.
While it’s hard not to be skeptical about whether ...Read more -->
Ever wonder why Canadian prescription drug prices are lower than those in the United States? Amongst the reasons is Canada has a “Patented Medicine Prices Review Board” that protects Canadian consumers from the outrageous prices drug manufactures want to charge.
The drug Thalidomide, made by Celgene, was originally priced at $400. Over time, Celgene increased its ...Read more -->
We have been reporting a lot lately on Big Pharma’s fraudulent ways. It has become abundantly clear that we can’t rely on pharmaceutical companies to make prescription drugs affordable.
Now, a legal case about drug pricing is being argued in front of the Supreme Court. And the Obama Administration has come down on the side of ...Read more -->
The pharmaceutical industry has surpassed the defense industry to become the biggest defrauder of the U.S. government, according to a recent study by Public Citizen, a highly respected consumer advocacy organization.
The report illustrates Big Pharma’s long history of deceitful and even illegal tactics. The majority of lawsuits filed against the drug companies stemmed from two ...Read more -->
We recently learned about the exorbitant amount of money Big Pharma spent on lobbying to influence health care reform. Just this past week, a new study in the American Journal of Public Health exposed the fact that pharmaceutical companies are also quietly doling out money to health advocacy organizations.
Groups like the National Alliance on Mental ...Read more -->
The pharmaceutical industry had a powerful role in shaping the recently passed Affordable Care Act. The pharmaceutical and health care products industry regularly spends exorbitant amounts of money on lobbying but they reached an all time high in lobby spending over the course of the debate.
The Center for Responsive Politics reported recently that the pharmaceutical ...Read more -->
The White House and the pharmaceutical industry are working together to eliminate prescription drug importation, under the guise of public safety.
If the administration is truly concerned about the safety of prescription drugs, perhaps it should protect itself and the public from the industry by using drug importation. An unaffordable drug is neither safe nor effective!
If ...Read more -->
The White House has initiated a Draconian crackdown on online pharmacies that puts the health of a millions of Americans in jeopardy. American consumers’ access to sources of safe and affordable prescription drugs has been endangered before, but never before like this.
Last month, Intellectual Property Czar Victoria Espinel, announced the government’s plans to completely shut ...Read more -->
U.S. courts are finally starting to hold big pharmaceutical companies accountable for their longtime, underhanded practice of drug price fixing.
Drug companies are currently facing lawsuits in 20 different states for reporting inflated wholesale drug prices.
Companies like Bristol-Myers Squibb and Abbot Laboratories have already agreed to settlements of hundreds of millions of dollars in false ...Read more -->
Prescription drug importation could make a big difference for a particular population of Americans—mental health patients. A recent study found that people on Medicaid with mental illnesses are having an especially hard time accessing their needed medications.
As many as a third of patients followed in the study, which appears in a recent issue of General ...Read more -->
An interesting article by Roger Bate, economist and drug safety expert at the American Enterprise Institute, came out yesterday calling for Republicans to
decriminalize personal drug importation.
Underscoring Mr. Bate’s position is his recognition, based on his own studies, that Americans who purchase brand name prescription drugs from non-US pharmacies can do so with confidence by ...Read more -->
The inflated price of prescription drugs and rising co-pays negatively impacts the health and well being of Americans.
As recently reported in The Wall Street Journal, more and more people are abandoning their prescription drugs at the pharmacy due to inability to pay.
Financially strapped patients should not have to choose between their needed medications and other ...Read more -->
prescription drug importation, international drug importation
Read more -->
Big pharmaceutical companies repeatedly name patient safety and public interest as their main points of opposition to prescription drug reimportation. Ironically, GlaxoSmithKline (GSK), the world’s third largest pharmaceutical company, recently admitted selling substandard drugs to Medicare and Medicaid.
GSK will pay $750 million to settle a lawsuit that charges them with knowingly producing fraudulent drugs. The ...Read more -->
Inspired by a generation of 60-somethings and born of necessity, online drug reimportation has become literally a “virtual lifeline” for many. This lifeline is now in grave danger of being destroyed by the very industry that gave birth to its necessity. Recent activities suggest that the $80 million dollar pledge that the U.S. pharmaceutical industry ...Read more -->
The pharmaceutical companies in America want all the privileges and benefits of a free market without the burdens of competition. Pharma will to go to any length to insure their monopolistic stranglehold on American consumers.
Recently Pharma has employed a variation on a phenomenon known as “Internet memes” targeting international online pharmacies. At its most basic ...Read more -->
The pharmaceutical industry fixes prices, prevents reimportation, and restricts competition from generics. When called on it, they deny the charges, admit nothing, and delay by raising specious, or empty, legal arguments.
A group of 17 Pharmacies, all located in California, have filed a lawsuit against 20 of our nation’s largest pharmaceutical companies. In the lawsuit, Clayworth ...Read more -->
Read more -->
Read more -->
The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading trade organization for U.S. drug companies, does not want U.S. consumers to have a choice of where they buy their drugs.
Read more -->
PhRMA keeps telling American consumers that the high cost of drugs is due to pricey research and development costs- where does all of their money go?
Read more -->
When Obama signed the health care bill, he promised it would provide access to health care, but it restricts access to safe, affordable drugs from abroad.
Read more -->
Read how brand-name pharmaceuticals, such as Lipitor and Nexium, are often half the price in Canada than they are in the United States.
Read more -->
Google changed its online advertising policy and banned international Internet and mail-order pharmacies from displaying advertisements to Americans
Read more -->
Google changed its online advertising policy and banned international Internet and mail-order pharmacies from displaying advertisements to Americans
Read more -->
A memo that was obtained by the Huffington Post indicates that the White House outlined a commitment of up to $80 billion to PhRMA.
Read more -->
US Senator Kohl requested a response from six major pharmaceutical companies to answer direct questions about the drug price discrepancies.
Read more -->
External (outside rxrights.org) Links
All links that are not rxrights.org (external) automatically open in a new window. No need to add <a href=”” target=”_blank”>.
How to add another FAQ
<h2 class=”title”>Question here?</h2><div class=”faqcontent”><p>Answer here</p></div>
How to add html code in header
RxRights has sent a letter to all House Judiciary Committee members regarding the threat that the Stop Online Privacy Act presents to public health.
Read more -->
RxRights is teaming up with Roger Bate of the American Enterprise Institute to shed some light on questions such as why people buy prescription drugs from international pharmacies. We have agreed to distribute and collect survey data from our supporters regarding this issue. Our email subscribers will soon receive a questionnaire ...Read more -->